data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Ocugen
(NASDAQ:OCGN)
$2.52
-0.08[-3.08%]
At close: Jul 6
$2.57
0.0500[1.98%]
After Hours: 6:34PM EDT
Day High/Low2.51 - 2.72
52 Week High/Low1.67 - 17.65
Open / Close2.59 / 2.52
Float / Outstanding157.9M / 215.7M
Vol / Avg.5.2M / 7M
Mkt Cap543.5M
P/E-
50d Avg. Price2.24
Div / Yield-
Payout Ratio-
EPS-0.09
Total Float157.9M

Ocugen (NASDAQ:OCGN), Quotes and News Summary

Ocugen (NASDAQ: OCGN)

Day High/Low2.51 - 2.72
52 Week High/Low1.67 - 17.65
Open / Close2.59 / 2.52
Float / Outstanding157.9M / 215.7M
Vol / Avg.5.2M / 7M
Mkt Cap543.5M
P/E-
50d Avg. Price2.24
Div / Yield-
Payout Ratio-
EPS-0.09
Total Float157.9M
Benzinga - Jun 21, 2022, 10:22AM
Benzinga - Jun 21, 2022, 7:02AM
Benzinga - Jun 15, 2022, 9:45AM
Benzinga - Jun 13, 2022, 7:05AM
Benzinga - Jun 10, 2022, 11:17AM
Benzinga - Jun 2, 2022, 7:10AM
Benzinga - May 24, 2022, 9:30AM
Benzinga - May 24, 2022, 7:13AM
Benzinga - May 23, 2022, 8:53AM
Benzinga - May 23, 2022, 6:36AM
Benzinga - May 13, 2022, 1:35PM
Benzinga - May 12, 2022, 6:11AM
Benzinga - May 11, 2022, 2:44PM
Benzinga - May 6, 2022, 6:33AM
Benzinga - Apr 26, 2022, 5:05AM
Benzinga - Apr 25, 2022, 1:44PM
Benzinga - Apr 25, 2022, 7:37AM
Benzinga - Apr 18, 2022, 8:52AM
Benzinga - Apr 18, 2022, 7:11AM
Benzinga - Apr 12, 2022, 9:28AM
Benzinga - Apr 12, 2022, 9:14AM
Benzinga - Apr 12, 2022, 8:43AM
Benzinga - Apr 12, 2022, 8:32AM
Benzinga - Apr 12, 2022, 8:32AM
Benzinga - Apr 8, 2022, 5:33AM
Benzinga - Apr 4, 2022, 12:15PM
Benzinga - Apr 1, 2022, 12:22PM
Benzinga - Apr 1, 2022, 7:37AM
Sector: Health Care.Industry: Biotechnology
Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-05
REV
Q1 2022Est.ActualSurprise
EPS-0.090
REV10.370M0-10.370M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Ocugen Questions & Answers

Q
How do I buy Ocugen (OCGN) stock?
A

You can purchase shares of Ocugen (NASDAQ: OCGN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Ocugen's (OCGN) competitors?
Q
What is the target price for Ocugen (OCGN) stock?
A

The latest price target for Ocugen (NASDAQ: OCGN) was reported by Roth Capital on Wednesday, June 15, 2022. The analyst firm set a price target for 8.00 expecting OCGN to rise to within 12 months (a possible 217.46% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Ocugen (OCGN)?
A

The stock price for Ocugen (NASDAQ: OCGN) is $2.52 last updated July 6, 2022, 8:00 PM UTC.

Q
Does Ocugen (OCGN) pay a dividend?
A

There are no upcoming dividends for Ocugen.

Q
When is Ocugen (NASDAQ:OCGN) reporting earnings?
A

Ocugen’s Q2 earnings are confirmed for Friday, August 5, 2022.

Q
Is Ocugen (OCGN) going to split?
A

There is no upcoming split for Ocugen.

Q
What sector and industry does Ocugen (OCGN) operate in?
A

Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.